Wedge Capital Management L L P Pfizer Inc Transaction History

Wedge Capital Management L L P

$5.71 Billion
Q3 2024

A detailed history of Wedge Capital Management L L P transactions in Pfizer Inc stock. As of the latest transaction made, Wedge Capital Management L L P holds 1,115,201 shares of PFE stock, worth $29.8 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares

1,115,201

Previous 1,221,888 8.73%

Holding current value

$29.8 Million

Previous $34.2 Million 5.6%

% of portfolio

0.56%

Previous 0.61%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	SELL	$27.7 - $31.39 $2.96 Million - $3.35 Million	-106,687 Reduced 8.73%	1,115,201 $32.3 Million
Q2 2024 Jul 17, 2024	BUY	$25.26 - $29.6 $30.9 Million - $36.2 Million	1,221,888 New	1,221,888 $34.2 Million
Q4 2023 Feb 01, 2024	SELL	$26.13 - $33.94 $1,280 - $1,663	-49 Reduced 0.45%	10,816 $311,000
Q3 2023 Oct 13, 2023	BUY	$32.09 - $37.51 $33,501 - $39,160	1,044 Added 10.63%	10,865 $360,000
Q2 2023 Jul 17, 2023	SELL	$36.12 - $41.79 $9,933 - $11,492	-275 Reduced 2.72%	9,821 $360,000
Q1 2023 Apr 11, 2023	BUY	$39.39 - $51.28 $6,932 - $9,025	176 Added 1.77%	10,096 $411,000
Q4 2022 Jan 17, 2023	BUY	$41.75 - $54.5 $6,387 - $8,338	153 Added 1.57%	9,920 $508,000
Q3 2022 Oct 13, 2022	SELL	$43.76 - $53.42 $2,363 - $2,884	-54 Reduced 0.55%	9,767 $427,000
Q2 2022 Jul 11, 2022	SELL	$46.53 - $55.17 $30.4 Million - $36 Million	-653,411 Reduced 98.52%	9,821 $515,000
Q1 2022 Apr 12, 2022	BUY	$45.75 - $56.69 $3.3 Million - $4.08 Million	72,041 Added 12.19%	663,232 $34.3 Million
Q4 2021 Jan 24, 2022	SELL	$41.32 - $61.25 $3.75 Million - $5.56 Million	-90,818 Reduced 13.32%	591,191 $34.9 Million
Q3 2021 Oct 14, 2021	SELL	$39.25 - $50.42 $4.26 Million - $5.47 Million	-108,485 Reduced 13.72%	682,009 $29.3 Million
Q2 2021 Jul 14, 2021	SELL	$35.91 - $40.68 $3.93 Million - $4.45 Million	-109,415 Reduced 12.16%	790,494 $31 Million
Q1 2021 Apr 12, 2021	BUY	$33.49 - $37.77 $5.8 Million - $6.55 Million	173,316 Added 23.85%	899,909 $32.6 Million
Q4 2020 Jan 08, 2021	SELL	$33.47 - $42.56 $686,971 - $873,544	-20,525 Reduced 2.75%	726,593 $26.7 Million
Q3 2020 Oct 08, 2020	SELL	$31.75 - $37.25 $8.62 Million - $10.1 Million	-271,364 Reduced 26.64%	747,118 $27.4 Million
Q2 2020 Jul 10, 2020	BUY	$30.12 - $36.54 $92,106 - $111,739	3,058 Added 0.3%	1,018,482 $33.3 Million
Q1 2020 Apr 13, 2020	SELL	$27.03 - $38.62 $1.25 Million - $1.79 Million	-46,402 Reduced 4.37%	1,015,424 $33.1 Million
Q4 2019 Jan 15, 2020	BUY	$32.92 - $37.36 $34.6 Million - $39.2 Million	1,049,967 Added 8853.76%	1,061,826 $41.6 Million
Q3 2019 Nov 01, 2019	SELL	$32.49 - $42.13 $25.1 Million - $32.5 Million	-772,095 Reduced 98.49%	11,859 $426,000
Q2 2019 Aug 01, 2019	BUY	$36.98 - $41.52 $28.7 Million - $32.2 Million	775,799 Added 9513.17%	783,954 $34 Million
Q1 2019 May 02, 2019	SELL	$37.5 - $41.2 $28.2 Million - $31 Million	-752,945 Reduced 98.93%	8,155 $346,000
Q4 2018 Jan 31, 2019	SELL	$38.47 - $43.86 $2.79 Million - $3.18 Million	-72,424 Reduced 8.69%	761,100 $33.2 Million
Q3 2018 Nov 01, 2018	SELL	$34.47 - $41.81 $413,674 - $501,761	-12,001 Reduced 1.42%	833,524 $36.7 Million
Q2 2018 Jul 31, 2018	SELL	$32.98 - $35.16 $4.39 Million - $4.68 Million	-133,132 Reduced 13.6%	845,525 $30.7 Million
Q1 2018 May 01, 2018	BUY	$31.91 - $37.02 $31 Million - $36 Million	971,854 Added 14285.67%	978,657 $34.7 Million
Q4 2017 Jan 31, 2018	BUY	$33.26 - $35.29 $4,490 - $4,764	135 Added 2.02%	6,803 $246,000
Q3 2017 Oct 31, 2017	BUY	$31.0 - $34.15 $206,708 - $227,712	6,668	6,668 $238,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wedge Capital Management L L P, based on Form 13F filings with the SEC.

News

Stay updated on Wedge Capital Management L L P with notifications on news.

Account

Wedge Capital Management L L P Pfizer Inc Transaction History